Can fasting hyperinsulinemia occur with a normal HbA1c?

The evidence strongly supports the assertion that fasting hyperinsulinemia can exist alongside a normal HbA1c. This occurs because elevated insulin acts as a compensatory mechanism to maintain stable blood glucose levels even as insulin resistance develops.

Clinical and effectiveness evidence

In the early stages of metabolic dysfunction, the body prioritizes glucose stability. Research, such as findings from the Whitehall II study and the Kraft Prediabetes Profile, demonstrates that fasting insulin levels often rise significantly—sometimes decades—before HbA1c or fasting glucose levels cross into the prediabetic or diabetic range.

• Insulin vs. Glucose: Clinical data show that patients can exhibit "Pattern 2" or "Pattern 3" hyperinsulinemic responses (characterized by elevated or delayed insulin peaks) while maintaining a fasting glucose below 100 mg/dL and an HbA1c below 5.7%.
• Predictive Value: Fasting insulin levels above 10–13 μU/mL in the presence of a normal HbA1c are early indicators of insulin resistance. HbA1c, which measures average glucose over three months, remains "normal" as long as the pancreas can secrete enough insulin to clear glucose from the bloodstream efficiently.

Mechanistic explanations

The maintenance of normal glucose levels despite underlying resistance is driven by "compensatory hyperinsulinemia."

• Beta-cell Adaptation: As peripheral tissues (skeletal muscle, liver, and adipose) become less sensitive to insulin signals, pancreatic beta-cells undergo hypertrophy (increase in size) and proliferation (increase in number). They also upregulate glucokinase activity and shift their glucose-sensing set-point, allowing them to secrete more insulin at lower glucose concentrations.
• GLUT4 Translocation: Insulin resistance reduces the efficiency of glucose transporter 4 (GLUT4) moving to the cell surface. To achieve the same rate of glucose uptake needed for euglycemia, a much higher concentration of circulating insulin is required to force the remaining sensitive receptors and transporters into action.
• Hepatic Clearance: Additionally, the liver may reduce its clearance of insulin from the blood. By slowing down the breakdown of insulin, the body keeps circulating levels higher for longer, which helps suppress hepatic glucose production and manage post-meal glucose spikes, effectively masking the metabolic strain.

Clinical implications

Because HbA1c is a proxy for the area under the curve (AUC) of glucose, it only begins to rise when the pancreas can no longer produce enough insulin to match the degree of resistance—a state known as beta-cell exhaustion.

• The "Silent" Phase: This compensatory state represents a "silent" phase of metabolic decline where traditional screening tools like HbA1c may provide a false sense of security regarding metabolic health.
• Early Intervention: Identifying hyperinsulinemia before the rise of HbA1c offers a critical window for lifestyle interventions that can reverse insulin resistance before irreversible beta-cell damage occurs.

Bottom line

Fasting hyperinsulinemia is frequently the first measurable sign of metabolic dysfunction, occurring while HbA1c remains normal because the overproduction of insulin successfully keeps average blood glucose in range.